Junshi Biosciences Announces Two Additional Indications for Toripalimab Included in China’s National Reimbursement Drug List

–the only anti-PD-1 monoclonal antibody in the NRDL for melanoma and nasopharyngeal carcinoma SHANGHAI, China, Dec. 03, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the company’s product toripalimab continues to be included in Category […]

Continue Reading

Asia Scoliosis Management Share, Size, Trends Insights Forecast To 2028

Published by Newstrail A new market study, titled “Asia Scoliosis Management Forecast 2021-2028” has been featured on Fortune Business Insights™. **Get Latest Updated Market Research Report with Free Sample Report* Market Overview The Asia scoliosis management market size is projected to reach USD 826.8 million by 2027, exhibiting a CAGR of 6.1% during the forecast […]

Continue Reading

Malaysia proposes reviving scrapped high-speed rail project

Published by Kyodo News Malaysia has proposed reviving talks with Singapore on a high-speed rail project that was abandoned earlier this year, Singapore Prime Minister Lee Hsien Loong said Monday. Lee said he discussed the Singapore-Kuala Lumpur high-speed rail project with his visiting Malaysian counterpart, Ismail Sabri Yaakob, who “suggested reviving discussions” on it. In […]

Continue Reading

Pharma group moves to curb sale of counterfeit medicines

Published by Philippine Star Louella Desiderio – The Philippine Star November 30, 2021 | 12:00am MANILA, Philippines — The Intellectual Property Office of the Philippines (IPOPHL) has forged a partnership with the Pharmaceutical Security Institute (PSI) to curb the increase in counterfeit medicines in the market. In a statement yesterday, the IPOPHL said the memorandum […]

Continue Reading